The Clinical Virology and Specimen Banking Core will continue to serve as a critical link between clinical researchers and laboratory based scientists participating in the UCSD CFAR. The Core stores specimens, isolates virus and quantifies virus load of patients participating in clinical research programs at UCSD and provides clinical and basic scientists with the necessary specimens with which to perform translational research of HIV pathogenesis. Specific functions to be performed by the Core will include: (1) Quantification of HIV RNA load in plasma cerebrospinal fluid (CSF), vaginal secretions and semen; (2) Primary isolation of HIV by culture of specimens of interests including peripheral blood mononuclear cells (PBMC), plasma macrophages, cerebrospinal fluid (CSF) and tissue specimens; (3) Quantification of infectious virus load as determined by quantitative culture of specimens including PBMC, plasma and CSF; (4) Storage of clinical specimens and virus isolates for future user by CFAR investigators; and (5) Cytomegalovirus (CMV) DNA quantification in clinical specimens and determination of CMV antiviral phenotypic and genotypic resistance. Specimens and viral isolated obtained by the Core are labelled, stored at -80 degrees Celsius or in liquid nitrogen (when required), and entered into a computerized data base for easy retrieval. Additional information regarding the source of each specimen, clinical data including disease status, CD4+ lymphocyte count, and treatment will be incorporated into the data base. To optimize clinical data retrieval, specimens obtained from persons participating in the major clinical HIV programs at UCSD including the Adult AIDS Clinical Trials Unit (AACTU), the Pediatric ACTU (PACTU), the California Collaborative Treatment Group (CCTG), the HIV Ocular Research Unit and the HIV Neurobehavioral Research Center (HNRC) will have their databases cross-linked with the Core. Thus, the Clinical virology and Specimen Banking Core will serve to optimize the utilization of well- characterized clinical specimens by making its extensive repository available to the wider community of investigators within the UCSD CFAR.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
2P30AI036214-06
Application #
6268173
Study Section
Project Start
1998-09-01
Project End
1999-02-28
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
6
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Fraser, Hannah; Mukandavire, Christinah; Martin, Natasha K et al. (2018) Modelling the impact of a national scale-up of interventions on hepatitis C virus transmission among people who inject drugs in Scotland. Addiction 113:2118-2131
Macal, Monica; Jo, Yeara; Dallari, Simone et al. (2018) Self-Renewal and Toll-like Receptor Signaling Sustain Exhausted Plasmacytoid Dendritic Cells during Chronic Viral Infection. Immunity 48:730-744.e5
Prakash, Katya; Gianella, Sara; Dubé, Karine et al. (2018) Willingness to participate in HIV research at the end of life (EOL). PLoS One 13:e0199670
Wertheim, Joel O; Murrell, Ben; Mehta, Sanjay R et al. (2018) Growth of HIV-1 Molecular Transmission Clusters in New York City. J Infect Dis 218:1943-1953
Dubé, Karine; Luter, Stuart; Lesnar, Breanne et al. (2018) Use of 'eradication' in HIV cure-related research: a public health debate. BMC Public Health 18:245
Papasavvas, Emmanouil; Lada, Steven M; Joseph, Jocelin et al. (2018) Analytical ART interruption does not irreversibly change pre-interruption levels of cellular HIV. AIDS :
Dubé, Karine; Gianella, Sara; Concha-Garcia, Susan et al. (2018) Ethical considerations for HIV cure-related research at the end of life. BMC Med Ethics 19:83
Chaillon, Antoine; Gianella, Sara; Lada, Steven M et al. (2018) Size, Composition, and Evolution of HIV DNA Populations during Early Antiretroviral Therapy and Intensification with Maraviroc. J Virol 92:
Bengtson, Angela M; Pence, Brian W; Eaton, Ellen F et al. (2018) Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015. Antivir Ther 23:363-372
Basova, Liana; Najera, Julia A; Bortell, Nikki et al. (2018) Dopamine and its receptors play a role in the modulation of CCR5 expression in innate immune cells following exposure to Methamphetamine: Implications to HIV infection. PLoS One 13:e0199861

Showing the most recent 10 out of 921 publications